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The kinetics of myosin regulatory light chain (MLC) phosphorylation by recombinant AMP-activated
protein kinase (AMPK) were compared with commercial AMPK from rat liver and smooth muscle
myosin light chain kinase (smMLCK). With identical amounts of activity units, initial rates of phos-
phorylation of MLC were at least 100-fold less with recombinant AMPK compared to smMLCK,
whereas with rat liver AMPK signiﬁcant phosphorylation was seen. In Madin-Darby Canine Kidney
cells, AMPK activation led to an increase in MLC phosphorylation, which was decreased by a Rho
kinase inhibitor without affecting AMPK activation. Therefore, MLC phosphorylation during energy
deprivation does not result from direct phosphorylation by AMPK.
Structured summary:
MINT-6800264: smMLCK (uniprotkb:P11799) phosphorylates (MI:0217) MLC (uniprotkb:
P08590) by protein kinase assay (MI:0424)
MINT-6800252: AMPK (uniprotkb:Q13131) phosphorylates (MI:0217) ACC2 (uniprotkb:
000763) by protein kinase assay (MI:0424)
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The AMP-activated protein kinase (AMPK) acts as an energy
sensor both at the cellular and systemic level in mammals [1,2].
AMPK is a heterotrimer consisting of a catalytic a subunit and
two regulatory subunits, b and c. Each subunit has multiple iso-
forms (a1, a2, b1, b2, c1, c2, c3) giving 12 possible combinations
of holoenzyme with different tissue distribution and subcellular
localization. AMPK can be activated by changes in the intracellular
AMP:ATP ratio [1], or via a rise in [Ca2+]i [2,3]. Activation by the up-
stream kinases, LKB1 (Peutz-Jeghers protein) and calcium/calmod-
ulin (Ca2+/CaM)-dependent protein kinase kinase-b occurs via
phosphorylation of Thr172 in the activation loop of the catalytic
a-subunits [2,3].chemical Societies. Published by E
PK, AMP-activated protein
-Darby Canine Kidney; MLC,
cle myosin light chain kinase.
ltot).In addition to its established role in energy homeostasis, AMPK
function extends to the regulation of cell structure [4,5]. In Madin-
Darby Canine Kidney (MDCK) cells, AMPK controls epithelial tight
junction assembly and cell polarity [6,7]. Myosin regulatory light
chain (MLC) phosphorylation initiates smooth muscle contraction
but also allows non-muscle myosin to interact with actin, thereby
inducing changes in the actin cytoskeleton critical for the regula-
tion of cell polarity [4]. AMPK-null mutants in Drosophila were re-
ported to be lethal with severe abnormalities in cell structure [8]
similar to the LKB1 knockout phenotype. In addition, epithelial
cells from a Drosophila AMPK a-subunit mutant lose their polarity
and overproliferate in response to energy stress [9]. Surprisingly, a
phosphomimetic MLC mutant rescued the AMPK-null defects in
cell polarity and mitosis in Drosophila and AMPK was claimed to di-
rectly phosphorylate the regulatory Ser19 smooth muscle myosin
light chain kinase (smMLCK) site of MLC in vitro and in vivo in
mammals and Drosophila [8]. However, in our previous studies
showing that smMLCK is phosphorylated and desensitized towards
Ca2+/CaM stimulation by AMPK [10], we checked that MLC was not
signiﬁcantly phosphorylated by AMPK in vitro. In order to resolvelsevier B.V. All rights reserved.
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thoroughly investigated the kinetics of MLC phosphorylation com-
pared with smMLCK.Fig. 1. Phosphorylation of (A) MLC peptide and (B) SAMS peptide by the AMPK and
smMLCK preparations in vitro. Initial rates of 32P-incorporation by 0.07 lg of rat
liver AMPK (4), 0.07 lg of recombinant AMPK (h) or 1 lg of smMLCK (s) into the
MLC peptide were 137 ± 18, 105 ± 7 and 194 ± 12 lUnits/50 ll of reaction mixture,
respectively, and into the SAMS peptide were 215 ± 9, 201 ± 26 and
2.3 ± 1.1 lUnits/50 ll of reaction mixture, respectively.
Fig. 2. Phosphorylation of (A) GST-ACC2 peptide and (B) MLC by the AMPK and
smMLCK preparations in vitro. Initial rates of 32P-incorporation by 0.07 lg of rat
liver AMPK (4), 0.07 lg of recombinant AMPK (h) or 1 lg of smMLCK (s) into GST-
ACC2 were 10.5 ± 1.3, 5.7 ± 0.9 and 0.3 ± 0.1 lUnits/50 lL of reaction mixture,
respectively, and into MLC were 12.0 ± 0.9, 1.3 ± 0.4 and >109 ± 4 lUnits/50 ll of
reaction mixture, respectively.2. Materials and methods
Heterotrimeric recombinant bacterially expressed a1b1c1 and
a2b1c1 AMPK complexes [11], chicken gizzard MLCK [12] and
myosin II light-chains [13] were puriﬁed as indicated. CaM, anti-
full-length smMLCK antibody (clone K36, Sigma), GST-human
acetyl-CoA carboxylase (ACC)2, puriﬁed rat liver AMPK (Upstate),
anti-rabbit Immunoglobulin G conjugated to IR dye 800 (Rockland
Inc., Philadelphia, PA), anti-sheep Immunoglobulin G conjugated to
Alexa 680 (Molecular Probes), anti-phospho-Thr172 AMPK a-sub-
unit and anti-phospho Ser19 MLC antibodies (Bioké), anti-phospho
Ser221 ACC2, anti-full-length ACC2 antibodies (Upstate), anti-full-
length MLC antibody (Sigma) and enhanced chemiluminescence
reagents (Thermoﬁsher) were from the indicated sources. Bacteri-
ally expressed recombinant CaMKKb, was kindly donated by Prof.
D. Carling (Imperial College London). Anti-a1/a2 AMPK antibodies
were kindly provided by Prof. D.G. Hardie (University of Dundee,
Scotland). The SAMS (containing the Ser79 AMPK site in ACC1)
and MLC (containing the Ser19 smMLCK site) peptides were kindly
synthesized by Dr. Vincent Stroobant (Ludwig Institute, Brussels)
[14,15]. A769662 was synthesized by AstraZeneca (Mölndal, Swe-
den) and kindly provided by Dr. A. Balendran.
2.1. In vitro phosphorylation and enzyme assays
Recombinant bacterially expressed a1b1c1 or a2b1c1 AMPK
(20 lg) was fully activated by recombinant bacterially expressed
CaMKKb [10].
To study phosphorylation by smMLCK, synthetic peptides
(0.2 mM), GST-ACC2 (5 lM) or puriﬁed MLC (5 lM) were incu-
bated in 50 ll of phosphorylation buffer containing 10 lg/ml
CaM, 1.5 mM CaCl2, 1 mM EGTA and 0.1 mM [c-32P] MgATP
(speciﬁc radioactivity 1000 cpm/pmol) at 30 C. Aliquots (5 ll)
were removed at various times to measure 32P incorporation
[10]. To study phosphorylation by the AMPK preparations, the
substrates were incubated in 50 ll of phosphorylation buffer con-
taining 0.2 mM AMP and 0.1 mM [c-32P] MgATP (speciﬁc radioac-
tivity 1000 cpm/pmol) at 30 C and 32P incorporation was
measured [10]. One unit of protein kinase activity corresponds to
the amount of enzyme that catalyzes the incorporation of
1 nmol/min of 32P under the assay conditions.
The second-order rate constant kcat/Km was determined under
pseudo-ﬁrst-order conditions ([S] 6 0.1Km). kcat/Km was calculated
from the pseudo-ﬁrst-order rate constant kcat[E]T/Km, where [E]T is
the total protein kinase enzyme concentration used.
2.2. Culture and incubation of MDCK cells
MDCK type I epithelial cells were kindly provided by Dr. P.
Courtoy (UCL, de Duve Institute, Brussels, Belgium) and cultured
as described [10]. The medium was replaced 24 h before incuba-
tion in DMEM without FBS and containing 5 mM glucose. Cells
were then incubated in the presence or absence of A769662
(20 lM) with or without pre-treatment with 1 lM H1152 Rho ki-
nase inhibitor (see ﬁgure legend). Preparation of MDCK lysates
and immunoblotting were performed as described [10].
For estimation of amounts of AMPK catalytic subunits in
the AMPK preparations by immunotitration, membranes were
incubated with primary antibodies after incubation in Odyssey
blocking buffer (Li-Cor Biosciences, Lincoln, NE) for detection and
quantiﬁcation with the Odyssey IR imager (Li-Cor Biosciences).2.3. Other methods
Protein concentrations were estimated by quantiﬁcation of
bands (by Odyssey infrared imaging) in Coomassie Blue stained
SDS–PAGE in which the kinase preparations were run alongside
known amounts of rabbit muscle aldolase (Boehringer), whose
concentration had been determined by measurement of A280 and
calculated from the molar extinction coefﬁcient. The concentration
of AMPK a-subunits in the rat liver AMPK preparation was mea-
sured by immunotitration with anti-a1/a2 AMPK antibodies using
a 1:1 mixture of recombinant bacterially expressed a1b1c1 and
a2b1c1 AMPK complexes for calibration. Commercial rat liver
AMPK was thus estimated to be at best 25–30% pure with respect
to its a-subunit content compared with a value of 9% based on
SDS–PAGE and Coomassie Blue staining quoted by the supplier.
All the results are expressed as the means ± S.E.M. for at least three
separate experiments.
3. Results and discussion
Ser19 of the smooth muscle/non-muscle MLC isoform is in a
suitable consensus for phosphorylation by AMPK [16], which is
more favorable in Drosophila than vertebrates. We ﬁrst standard-
ized the activity of puriﬁed MLCK, recombinant AMPK and the
commercial rat liver preparation used by Lee et al. [8] knowing that
the synthetic peptide containing Ser19 of smooth muscle MLC [17]
is a common substrate for AMPK and MLCK. By adjusting the
amounts of AMPK and MLCK, we obtained about the same initial
rates of phosphorylation of this peptide with the three enzyme
Table 1
Comparison of maximal stoichiometries and catalytic efﬁciencies of phosphorylation of GST-ACC2 and MLC by the AMPK and smMLCK preparations. Stoichiometries of 32P-
incorporation after 30 min of incubation were calculated from the data shown in Fig. 2. kcat/Km was determined by the direct method under pseudo-ﬁrst-order conditions
([S] 6 0.1Km). Protein kinase incubations (50 ll) for the phosphorylation of 0.2, 0.02 and 0.1 lM MLC contained 3.9 nM rat liver AMPK, 38.7 nM recombinant AMPK and 2.9 nM
smMLCK, respectively. Protein kinase incubations (50 ll) for the phosphorylation of 0.5 lM GST-ACC2 contained 9.7 nM rat liver AMPK or 10.7 nM recombinant AMPK. Aliquots
(5 ll) were removed at 5, 10, 15, 20, 30 and 40 min for the determination of 32P-incorporation. Pseudo-ﬁrst-order rate constants were calculated from the exponential rate of
disappearance of substrate obtained by subtraction, at each time-point, of the amount of phosphorylated product formed from the plateau of total 32P-incorporation into the
substrate protein. kcat/Km was then calculated. The calculation of kcat/Km for rat liver AMPK was based on the estimation of a-catalytic subunit concentration in the preparation
after immunotitration with a1/a2-AMPK antibodies as described under Section 2. N.M. – not measured.
MLC GST-ACC2
Stoichiometry (mol/mol) kcat/Km (M1 s1) Stoichiometry (mol/mol) kcat/Km (M1 s1)
smMLCK 0.90 ± 0.08 4.70 ± 0.52  105 0.044 ± 0.005 N.M.
Rat liver AMPK 0.60 ± 0.07 3.93 ± 0.21  105 0.45 ± 0.04 1.52 ± 0.04  105
Recombinant AMPK 0.10 ± 0.01 0.20 ± 0.02  105 0.31 ± 0.04 0.85 ± 0.08  105
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all subsequent experiments. The two AMPK preparations gave sim-
ilar rates of phosphorylation of the SAMS peptide, whereas the rate
of phosphorylation by smMLCK was 100-fold less (Fig. 1B).
The ability of the three preparations to phosphorylate GST-
ACC2 was then compared. Recombinant AMPK and rat liver AMPK
gave similar rates of phosphorylation (5.7 ± 0.9 and 10.5 ± 1.3 lU-
nits, respectively), whereas smMLCK poorly phosphorylated GST-
ACC2 (0.3 ± 0.1 lUnits), as expected (Fig. 2A). The stoichiometries
of GST-ACC2 phosphorylation by the two AMPK preparations after
30 min of incubation were similar (Table 1). However, with puri-
ﬁed MLC as a substrate, the initial rate of phosphorylation was at
least 100-times less with recombinant AMPK than with smMLCK
(1.3 ± 0.4 lUnits vs. 109 ± 4 lUnits), but a reasonable rate was ob-
tained with rat liver AMPK (12.0 ± 0.9 lUnits) (Fig. 2B). As for
a1b1c1 AMPK, recombinant a2b1c1 AMPK phosphorylated puri-
ﬁed MLC at a very low rate (2.3 ± 0.1 lUnits) under identical con-
ditions. Although we did not eliminate CaMKKb from the
activated recombinant AMPK mixtures, its contribution towards
MLC phosphorylation was very small and about half the rate ob-
served with the recombinant AMPK preparations. The maximal
stoichiometry of MLC phosphorylation by smMLCK and rat liverFig. 3. Effect of H1152 on A769662-induced AMPK Thr172, ACC Ser221 and MLC Ser19 ph
of 20 lM A769662 for 30 min with or without 60 min of pre-treatment with 1 lM H11
phospho Thr172 AMPK a-subunit, anti-phospho Ser221 ACC or anti-phospho Ser19 MLC
controls for detection by chemiluminescence and scanning densitometry. *Indicates a sign
to treatment without inhibitor.AMPK (0.90 ± 0.08 and 0.60 ± 0.07 mol/mol, respectively) was not
far from stoichiometric, whereas it was very low with recombinant
AMPK (0.10 ± 0.01 mol/mol, Table 1).
To compare the catalytic efﬁciencies of MLC and GST-ACC2
phosphorylation by the three preparations, we calculated kcat/Km
by direct estimate under pseudo-ﬁrst-order conditions (see Section
2 and Table 1). The catalytic efﬁciencies of recombinant and rat li-
ver AMPK towards GST-ACC2 were of comparable magnitude (Ta-
ble 1). However, kcat/Km of smMLCK and rat liver AMPK towards
MLC was more than 20-times greater than with recombinant
AMPK (Table 1).
Therefore, we conclude that MLCs are not a physiological sub-
strate of AMPK and that the rat liver AMPK preparation used in
the studies of Lee et al. [8] is likely contaminated by kinases other
than MLCK capable of phosphorylating MLC. As such, caution
should be exercised when using commercial AMPK for the
in vitro phosphorylation of potential AMPK targets. Several protein
kinases have been speculated to be able to phosphorylate the reg-
ulatory site of MLC in smooth muscle and non-muscle cells. These
include Rho-activated kinase [18,19], calmodulin-dependent pro-
tein kinase I [20], calmodulin-dependent protein kinase II [21], zip-
per-interacting protein kinase [22], p21-activated protein kinaseosphorylation in MDCK cells. MDCK cells were incubated in the presence or absence
52 Rho kinase inhibitor. Cell lysates were analyzed by immunoblotting with anti-
antibodies along with the appropriate anti-full length protein antibodies as loading
iﬁcant difference (P < 0.05, unpaired t-test) with respect to the value corresponding
28 L. Bultot et al. / FEBS Letters 583 (2009) 25–28[18] and integrin-linked kinase [23]. Although many of these ki-
nases can phosphorylate MLC in isolation, this is not the case when
bound to myosin. Furthermore, most of the kinases mentioned
above are now thought to be involved in regulating MLC phosphor-
ylation, not by direct phosphorylation, but by phosphorylating and
inactivating myosin phosphatase, either via the myosin targeting
subunit or the protein kinase C-potentiated inhibitor protein of
17 kDa [24].
Lastly, we were able to show that in MDCK cells incubated with
A-769662, AMPK was activated, as reﬂected by an increase in
AMPK Thr172 and ACC Ser221 phosphorylation, and that this
was associated with an increase in MLC phosphorylation (Fig. 3),
thus conﬁrming the results of Lee et al. [8] in human LS174T cells
where AMPK activation by 2-deoxyglucose treatment led to MLC
phosphorylation. However, the increase in MLC phosphorylation
induced by A-769662 in MDCK cells was markedly decreased by
the H-1152 Rho kinase inhibitor, without affecting AMPK activa-
tion (Fig. 3). Therefore, it is tempting to speculate that AMPK acti-
vation-induced increase in MLC phosphorylation in epithelial cells
is indirect and mediated by inactivation of myosin phosphatase via
Rho kinase. In conclusion, we do not contest the ﬁnding that AMPK
activation by energy deprivation induces cell structure changes via
MLC phosphorylation, only that this does not occur by direct phos-
phorylation of MLC by AMPK.
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